Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.53 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.53 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | DHFR | P00374 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | MPO | P05164 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.53 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.53 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28205348 | 0.87 | TSHR (0.61) | TSHRCYP2C9CYP3A4HIF1AKMT2A | |
| SCHEMBL8041465 | 0.87 | KDM4E (0.61) | TSHRCYP2C9CYP3A4HIF1AKMT2A | |
| SCHEMBL69352 | 0.83 | TSHR (0.68) | TSHRCYP2C9HIF1AAKR1C3NAPRT | |
| SCHEMBL17938486 | 0.81 | TSHR (0.66) | TSHRCYP2C9HIF1AAKR1C3NAPRT | |
| SCHEMBL29225318 | 0.81 | TSHR (0.57) | TSHRCYP2C9CYP3A4HIF1AKMT2A | |
| Phthalic Acid SCHEMBL27960519 | 0.79 | CYP3A4 (0.70) | TSHRCYP2C9CYP3A4HIF1AKMT2A | |
| SCHEMBL10022812 | 0.79 | KDM4C (0.45) | TSHRCYP2C9CYP3A4HIF1AKMT2A | |
| SCHEMBL3306785 | 0.79 | ESR1 (0.47) | TSHRCYP3A4TRPA1CYP1A2ALDH1A1 | |
| SCHEMBL11490533 | 0.79 | PTPN1 (0.64) | CYP2C9CYP3A4KMT2AALDH1A1KDM4E | |
| SCHEMBL7477210 | 0.79 | HPGD (0.50) | TSHRCYP2C9HIF1AKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9775906-B2 | Hydrogel polymeric compositions and methods | INCEPT LLC (US) | 2017-10-03 | — | — | US | disclosed |
| US-9504753-B2 | Nanometer-sized prodrugs of NSAIDs | CEDARS-SINAI MEDICAL CENTER (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160296623-A1 | HYDROGEL POLYMERIC COMPOSITIONS AND METHODS | INCEPT, LLC | 2016-10-13 | — | — | US | disclosed |
| US-9456985-B2 | Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drug | UPSHER-SMITH LABORATORIES, INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-9370485-B2 | Hydrogel polymeric compositions and methods | INCEPT, LLC (US) | 2016-06-21 | — | — | US | disclosed |
| US-20160115192-A1 | ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTICANCER DERIVATIVES OF TRIPTOLIDE AND NANOSPHERES THEREOF | CEDARS-SINAI MEDICAL CENTER (US) | 2016-04-28 | — | — | US | disclosed |
| US-20160045620-A1 | USE OF NANOMETER-SIZED PRODRUGS OF NSAIDs TO TREAT TRAUMATIC BRAIN INJURY | CEDARS-SINAI MEDICAL CENTER (US) | 2016-02-18 | — | — | US | disclosed |
| US-20150238423-A1 | Sustained-Released Product Comprising a Combination of a Non-Opioid Amine and a Non-Steroidal, Anti-Inflammatory Drug | UPSHER-SMITH LABORATORIES, INC. (US) | 2015-08-27 | — | — | US | disclosed |
| US-20150182462-A1 | Opioid-Containing Oral Pharmaceutical Compositions and Methods | UPSHER-SMITH LABORATORIES, INC. | 2015-07-02 | — | — | US | disclosed |
| US-9023390-B2 | Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug | UPSHER-SMITH LABORATORIES, INC. (US) | 2015-05-05 | — | — | US | disclosed |
| US-20110275658-A1 | OPIOID-CONTAINING ORAL PHARMACEUTICAL COMPOSITIONS AND METHODS | UPSHER-SMITH LABORATORIES, INC. (US) | 2011-11-10 | — | — | US | disclosed |
| US-8053591-B2 | Functionalized biodegradable triclosan monomers and oligomers for controlled release | BEZWADA BIOMEDICAL, LLC (US) | 2011-11-08 | — | — | US | disclosed |
| US-8053591-B2 | Functionalized biodegradable triclosan monomers and oligomers for controlled release | BEZWADA BIOMEDICAL, LLC (US) | 2011-11-08 | — | — | US | disclosed |
| US-8026285-B2 | Control release of biologically active compounds from multi-armed oligomers | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-27 | — | — | US | disclosed |
| US-8026285-B2 | Control release of biologically active compounds from multi-armed oligomers | BEZWADA BIOMEDICAL, LLC (US) | 2011-09-27 | — | — | US | disclosed |
| US-20110217248-A1 | Topical Composition | ISW GROUP, INC. (US) | 2011-09-08 | — | — | US | disclosed |
| US-20110086073-A1 | NANOMETER-SIZED PRODRUGS OF NSAIDs | CEDARS-SINAI MEDICAL CENTER (US) | 2011-04-14 | — | — | US | disclosed |
| US-20090105352-A1 | FUNCTIONALIZED BIODEGRADABLE TRICLOSAN MONOMERS AND OLIGOMERS FOR CONTROLLED RELEASE | BEZWADA BIOMEDICAL, LLC (US) | 2009-04-23 | — | — | US | disclosed |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2009-03-19 | — | — | US | disclosed |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | BEZWADA BIOMEDICAL, LLC (US) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275658-A1 | OPIOID-CONTAINING ORAL PHARMACEUTICAL COMPOSITIONS AND METHODS | OPRK1, OPRM1, OPRL1 | TSHR 4135/4885CYP2C9 34/4885CYP3A4 114/4885 |
| US-20090105352-A1 | FUNCTIONALIZED BIODEGRADABLE TRICLOSAN MONOMERS AND OLIGOMERS FOR CONTROLLED RELEASE | LTN1, PARN, TLR3 | TSHR 2565/4885CYP2C9 1015/4885CYP3A4 984/4885 |
| US-20150182462-A1 | Opioid-Containing Oral Pharmaceutical Compositions and Methods | OPRK1, OPRM1, OPRL1 | TSHR 4135/4885CYP2C9 34/4885CYP3A4 114/4885 |
| US-20090076174-A1 | CONTROL RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS FROM MULTI-ARMED OLIGOMERS | MME, CTSA, ALG1 | TSHR 3963/4885CYP2C9 2996/4885CYP3A4 2364/4885 |
| US-20160296623-A1 | HYDROGEL POLYMERIC COMPOSITIONS AND METHODS | CRYAA, CRYAB, UACA | TSHR 2992/4885CYP2C9 4107/4885CYP3A4 4809/4885 |
| US-20110086073-A1 | NANOMETER-SIZED PRODRUGS OF NSAIDs | PTGS1, NFKBIA, NOS1 | TSHR 4341/4885CYP2C9 186/4885CYP3A4 247/4885 |
| US-20110217248-A1 | Topical Composition | S100A8, S100P, BPTF | TSHR 4665/4885CYP2C9 2781/4885CYP3A4 2773/4885 |
| US-20160045620-A1 | USE OF NANOMETER-SIZED PRODRUGS OF NSAIDs TO TREAT TRAUMATIC BRAIN INJURY | PTGS1, PTGS2, PTGES3 | TSHR 4828/4885CYP2C9 498/4885CYP3A4 651/4885 |
| US-20150238423-A1 | Sustained-Released Product Comprising a Combination of a Non-Opioid Amine and a Non-Steroidal, Anti-Inflammatory Drug | OPRK1, OPRM1, SIGMAR1 | TSHR 3692/4885CYP2C9 114/4885CYP3A4 179/4885 |
| US-20160115192-A1 | ANTIOXIDANT, ANTI-INFLAMMATORY AND ANTICANCER DERIVATIVES OF TRIPTOLIDE AND NANOSPHERES THEREOF | PDCD1, SOD1, PDCD1LG2 | TSHR 4097/4885CYP2C9 1275/4885CYP3A4 1233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.